Industry News | tctmd.com

News Industry News

Medtronic IN.PACT Admiral DCB Maintains Durable, Consistent and Safe Outcomes in Challenging Peripheral Cases

April 26, 2016

News Industry News

Boston Scientific Receives U.S. FDA Approval For ImageReady™ MR-Conditional Pacing System

April 26, 2016

News Industry News

VENITI® Completes First Use Of VICI VERTO VENOUS STENT™, Novel Venous Stent System

April 22, 2016

News Industry News

AV Medical Announces Successful Completion of 30 Patient Study with its Innovative Angioplasty Balloon Catheter, Chameleon™

April 22, 2016

News Industry News

GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains Health Canada Approval

April 21, 2016

News Industry News

NanoCor Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) for Carfostin®

April 20, 2016

News Industry News

Real-World Study Shows 72 Percent of Atrial Fibrillation Would Have Gone Undiagnosed in Stroke Patients if Cardiac Monitoring Had Been Limited to 30 Days

April 20, 2016

News Industry News

Boston Scientific Announces CE Mark For MRI Labeling Of Emblem™ S-ICD Systems

April 20, 2016

News Industry News

CardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart Failure

April 19, 2016

News Industry News

St. Jude Medical Announces Launch and First US Implants of MultiPoint Pacing Technology

April 18, 2016

Subscribe to Industry News

Advertisement

Medtronic IN.PACT Admiral DCB Maintains Durable, Consistent and Safe Outcomes in Challenging Peripheral Cases

Boston Scientific Receives U.S. FDA Approval For ImageReady™ MR-Conditional Pacing System

VENITI® Completes First Use Of VICI VERTO VENOUS STENT™, Novel Venous Stent System

AV Medical Announces Successful Completion of 30 Patient Study with its Innovative Angioplasty Balloon Catheter, Chameleon™

GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains Health Canada Approval

NanoCor Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) for Carfostin®

Real-World Study Shows 72 Percent of Atrial Fibrillation Would Have Gone Undiagnosed in Stroke Patients if Cardiac Monitoring Had Been Limited to 30 Days

Boston Scientific Announces CE Mark For MRI Labeling Of Emblem™ S-ICD Systems

CardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart Failure

St. Jude Medical Announces Launch and First US Implants of MultiPoint Pacing Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content